About Contact Us Careers

Soft Tissue Allografts Market Size and Forecast, by Type (Cartilage, Tendon, Meniscus, Dental, Collagen, Amniotic Allograft); Application (Orthopedic, Dentistry, Wound Care); End-user (Hospitals, Orthopedic Clinics, Aesthetic Centers, Dental Clinics) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 4344
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Soft Tissue Allografts Market Outlook:

Soft Tissue Allografts Market size was over USD 5.04 Billion in 2025 and is anticipated to cross USD 9.2 Billion by 2035, growing at more than 6.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of soft tissue allografts is assessed at USD 5.32 Billion.

Soft-Tissue-Allografts-Market-scope
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The growth of the market can be attributed to the increasing trauma cases related to accidents, sports injuries, and others. According to the data from 2021 from the Accident Compensation Corporation (ACC), there were roughly 692 million in injury claims related to sports and recreation. Moreover, according to the National Library of Medicine, 33 million skeletal injuries occur in the United States each year, of which 50% are tendon and ligament injuries.

In addition to these, factors that are believed to fuel the market growth of soft tissue allografts include the increasing count of anterior cruciate ligament (ACL) sprains and tears. Allograft tissue is the tissue that has been surgically implanted from one person to another. Soft tissue allografts are the replacement tissues used in an anterior cruciate ligament (ACL) to repair the damaged ligament, torn menisci, osteochondral defects, and spinal surgery. Utilization of allografts for soft tissue reconstruction results in less donor tissue site mortality and relatively short surgical time. For instance, in the United States, the prevalence rate of ACL sprains and tears ranges from 110,000 to 226,000 per year.

Key Soft Tissue Allografts Market Insights Summary:

  • Regional Highlights:

    • North America’s soft tissue allografts market will hold around 44.2% share by 2035, driven by rising prevalence of arthritis and associated healthcare expenditure.

  • Segment Insights:

    • The tendon allograft segment in the soft tissue allografts market is anticipated to secure a significant share by 2035, attributed to rising cases of tendinitis, especially in older people and athletes.
    • The dentistry segment in the soft tissue allografts market is expected to hold the largest share by 2035, attributed to the rising number of tooth loss in the aging population.

  • Key Growth Trends:

    • Growing Incidences of Sports Injuries
    • Rising Prevalence of Osteoarthritis

  • Major Challenges:

    • High treatment cost of soft tissues
    • Shortage of skilled workers

  • Key Players: Stryker Corporation, ALON SOURCE GROUP, CONMED Corporation, LifeSciences Corporation, Organogenesis Inc., RTI Surgical, Inc., MIMEDX, Inc., Xtant Medical Holdings, Inc., Globus Medical, Inc., Bone Bank Allografts.

Global Soft Tissue Allografts Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 5.04 Billion
    • 2026 Market Size: USD 5.32 Billion
    • Projected Market Size: USD 9.2 Billion by 2035
    • Growth Forecasts: 6.2% CAGR (2026-2035)

  • Key Regional Dynamics:

    • Largest Region: North America (44.2% Share by 2035)
    • Fastest Growing Region: Asia Pacific
    • Dominating Countries: United States, Germany, Japan, United Kingdom, China
    • Emerging Countries: China, Japan, South Korea, India, Germany

    • Last updated on : 9 September, 2025

Growth Drivers

  • Growing Incidences of Sports Injuries - Sports injuries happen when exercising or playing a sport. These injuries affect the bones, muscles, tendons, ligaments, and other body structures. As per a report, in the United States, every year, approximately 4 million kids aged 14 and under suffer injuries while playing sports or engaging in leisure activities.

  • Rising Prevalence of Osteoarthritis - Older people have a higher risk to develop osteoarthritis. The breakdown of cartilage, a stretchy material that reduces the friction in joints, causes primary osteoarthritis. For instance, around 3 to 6% of people worldwide suffer from osteoarthritis. It is a cause of moderate to severe impairment in nearly 44 million people.

  • Increase in Trauma Cases – As per the World Health Organization, every year, approximately 1.3 million people's lives are ended prematurely as an outcome of a road accident. Non-fatal injuries affect between 20 and 50 million people who have become disabled as a consequence of their injury. These injuries many times cause wear and tear of bones and muscles, breaking the stability of the skeletal system.

  • Upsurge in Musculoskeletal Diseases - The musculoskeletal issues can affect the muscles, bones, and joints. The severity of MSDs can vary. In some cases, they cause pain and discomfort and in severe situations, it can lead to allografting. Musculoskeletal issues entail a variety of problems, including tendinitis, carpel tunnel syndrome, and fibromyalgia. Nearly 1.71 billion people around the world have musculoskeletal diseases

  • Technological Advancement in Allografts - The newest technology from the CYGNUS family of amniotic tissue allografts, CYGNUS Matrix Disks, was just released, by Vivex Biologics, Inc. With enhanced handling and increased workability, CYGNUS® Matrix Disks are a flexible, multi-layer allograft that preserves the amnion layer

Challenges

  • High treatment cost of soft tissues - The average cost of allograft ACL restoration was around USD 5500. ACL reconstruction is a commonly practiced orthopedic operation. Though there have been many technological advancements in allography, the cost price of the operation is also increasing.  Moreover, in comparison to autografts, allografts are more expensive.
  • Shortage of skilled workers
  • Lack of medical reimbursement policies for soft tissue allografts

Soft Tissue Allografts Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Period

2026-2035

CAGR

6.2%

Base Year Market Size (2025)

USD 5.04 Billion

Forecast Year Market Size (2035)

USD 9.2 Billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Soft Tissue Allografts Market Segmentation:

Application Segment Analysis    

The global soft tissue allografts market is segmented and analyzed for demand and supply by application in orthopedics, dentistry, wound care, and others. Out of the four types of application, the dentistry segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the rising number of tooth loss in the aging population, and tooth-related issues i.e., replacement of missing teeth in people that require effective treatment. For instance, until 2019, around 4 million people in the United States alone had dental implants, and this number is expanding by 520,000 annually.

Type Segment Analysis    

The global soft tissue allografts market is also segmented and analyzed for demand and supply by type into cartilage allograft, tendon allograft, meniscus allograft, dental allograft, collagen allograft, and amniotic allograft. Amongst these six segments, the tendon allograft is expected to garner a significant share. The segment growth is attributed to rising cases of tendinitis and especially in older people. The most typical sites for tendinitis to develop with age include the Achilles tendon, hip, elbow, shoulder, and base of the thumb. This is due to the deterioration of bones and tissues as well as chronic diseases like diabetes and arthritis. According to the National Library of Medicine, adults over the age of 60 had a much greater incidence of rotator cuff tendon rupture, long head of the biceps tendon lesions, and rotator illnesses. Moreover, rising cases of tendon injuries during sports and other athletic activities are expected to augment segment growth. Around 30% of runners, 14% of volleyball players, and 12% of basketball players experience a tendon injury each year.

Our in-depth analysis of the global market includes the following segments:

                   By Type
  • Cartilage Allograft
  • Tendon Allograft
  • Meniscus Allograft
  • Dental Allograft
  • Collagen Allograft
  • Amniotic Allograft

                    By Application
  • Orthopedic
  • Dentistry
  • Wound Care
  • Others

                   By End-User
  • Hospitals
  • Orthopedic Clinics
  • Aesthetic Centers
  • Dental Clinics
  • Others
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Soft Tissue Allografts Market Regional Analysis:

North American Market Insights             

North America region is anticipated to hold over 44.2% market share by 2035. The growth of the market can be attributed majorly to the rising prevalence of arthritis, and rising healthcare expenditure on its treatment. In the United States, around 59 million adults, or approximately 24% of the population, suffer from arthritis.  Osteoarthritis is the most prevalent type of arthritis. Gout and lupus are further kinds. Moreover, the annual cost of medical care for arthritis is around USD 300 billion. In addition to this, the surging need for rheumatoid arthritis treatment is another substantial factor that is estimated to boost the market growth further in the region over the projected time frame.

Soft-Tissue-Allografts-Market-regional
Get Strategic Analysis by Region Now: Request Free Sample PDF

Soft Tissue Allografts Market Players:

    • Stryker Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • ALON SOURCE GROUP
    • CONMED Corporation
    • LifeSciences Corporation
    • Organogenesis Inc.
    • RTI Surgical, Inc.
    • MIMEDX, Inc.
    • Xtant Medical Holdings, Inc.
    • Globus Medical, Inc.
    • Bone Bank Allografts

Recent Developments

  •  AlloSource, one of the leading providers of allograft in the United States, announced the launch of AlloMend Extra Large (XL) Acellular Dermal Matrix (ADM). It is so far the biggest dermal graft launched by the company. It is available in mesh and non-mesh variations for use in demanding soft tissue applications.

  • RTI Surgical, Inc. and Zimmer Biomet partnered with the American Academy of Implant Dentistry Foundation (AAIDF) to provide dental implants and wound care products for an initiative supporting veterans of the United States Armed Forces.

 

  • Report ID: 4344
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of soft tissue allografts is assessed at USD 5.32 Billion.

The global soft tissue allografts market size was valued at around USD 5.04 Billion in 2025 and is projected to grow at a CAGR of more than 6.2%, reaching USD 9.2 Billion revenue by 2035.

North America’s soft tissue allografts market will hold around 44.2% share by 2035, driven by rising prevalence of arthritis and associated healthcare expenditure.

Key players in the market include Stryker Corporation, ALON SOURCE GROUP, CONMED Corporation, LifeSciences Corporation, Organogenesis Inc., RTI Surgical, Inc., MIMEDX, Inc., Xtant Medical Holdings, Inc., Globus Medical, Inc., Bone Bank Allografts.

Soft Tissue Allografts Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos